Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Alzheimer's disease
Alzheimer's disease
Biohaven Pharma to continue late-stage study of Alzheimer's treatment
Reuters
Fri, 12/6/19 - 09:34 pm
Biohaven Pharmaceuticals
Alzheimer's disease
troriluzole
Biogen Points to Enrollment and Dosing to Explain Alzheimer’s Results
Xconomy
Thu, 12/5/19 - 11:35 pm
Biogen
Alzheimer's disease
aducanumab
Worldwide Clinical Trials
The clearest picture of Biogen's Alzheimer's drug is still fuzzy
Biopharma Dive
Thu, 12/5/19 - 11:34 pm
Biogen
Alzheimer's disease
clinical trials
aducanumab
New Biogen data showed no major safety issues for its Alzheimer's drug
Reuters
Thu, 12/5/19 - 12:16 pm
Biogen
safety
Alzheimer's disease
aducanumab
clinical trials
6 Experimental Alzheimer’s Disease Diagnostics Projects Get Funding Boost
Xconomy
Wed, 12/4/19 - 11:13 pm
Alzheimer's disease
diagnostics
DiamiR Biosciences
RetiSpec
What to watch as Biogen presents its all-important Alzheimer's data
Biopharma Dive
Wed, 12/4/19 - 11:11 pm
Biogen
clinical trials
Alzheimer's disease
aducanumab
Biogen’s stock could fall 10% on new Alzheimer’s drug data this week, top analyst says
CNBC
Tue, 12/3/19 - 10:18 pm
Biogen
Alzheimer's disease
aducanumab
Analyst: Biogen's aducanumab is not getting approved absent a deus ex machina
Fierce Biotech
Mon, 12/2/19 - 10:44 am
Biogen
aducanumab
FDA
Alzheimer's disease
Why Biogen's Recent Rebound May Not Last -- at Least for Now
Motley Fool
Wed, 11/27/19 - 10:43 am
Biogen
MS
multiple sclerois
Alzheimer's disease
Tecfidera
aducanumab
Biogen’s top scientist nearly dares FDA not to approve Alzheimer’s drug
Stat
Thu, 11/21/19 - 11:20 pm
Biogen
aducanumab
FDA
Alzheimer's disease
Roche tests 'brain shuttle' in humans in Alzheimer's project
Reuters
Mon, 11/11/19 - 08:00 pm
Roche
Alzheimer's disease
monoclonal antibodies
gantenerumab
Here's Why Biogen Stock Shot Up 28% in October
Motley Fool
Sun, 11/10/19 - 07:51 pm
Biogen
Alzheimer's disease
aducanumab
China's Alzheimer’s Drug Approval Raises Hopes and Skepticism
BioSpace
Tue, 11/5/19 - 11:58 pm
Alzheimer's disease
China
Shanghai Green Valley Pharmaceuticals
Chinese pharma claims first Alzheimer’s drug approval since 2003
Pharmaforum
Mon, 11/4/19 - 10:34 am
China
Alzheimer's disease
Shanghai Green Valley Pharmaceuticals
Oligomannate
Small Alzheimer's hopeful biotech nabs $15M series B for metabolic drug approach
Fierce Biotech
Mon, 11/4/19 - 09:56 am
T3D Therapeutics
NIH
Alzheimer's disease
Research Roundup: What Are Microproteins and What Do They Do and More
BioSpace
Sat, 11/2/19 - 07:45 pm
microproteins
Alzheimer's disease
universal flu vaccine
R&D
Allergan pays $750m to avoid Alzheimer’s drug lawsuit
Pharmaforum
Mon, 10/28/19 - 11:31 pm
Allergan
Namenda
Alzheimer's disease
settlement
Biogen Alzheimer's Case Shows Danger of Trials Killing Good Drugs
Yahoo/Guru Focus
Mon, 10/28/19 - 11:09 pm
Biogen
Alzheimer's disease
aducanumab
clinical trials
drug development
More Details Emerge on Biogen’s Alzheimer’s Comeback
BioSpace
Mon, 10/28/19 - 10:31 am
Biogen
Alzheimer's disease
aducanumab
An Alzheimer’s patient on what was lost when Biogen shut down its trial, and what may be gained again
Stat
Fri, 10/25/19 - 10:40 am
Biogen
patients
Alzheimer's disease
aducanumab
clinical trials
Pages
« first
‹ previous
…
22
23
24
25
26
27
28
29
30
…
next ›
last »